Arnaud Lesegretain is the founder of Orano Med. Orano Med has raised $300M in total funding. Based in Paris, France.
Arnaud Lesegretain is the CEO of Orano Med, a company focused on developing targeted alpha therapies in oncology. He has extensive experience in late-stage development and commercialization within the pharmaceutical industry. Before joining Orano Med, he served as Vice President Oncology R&D Global Program Leader at Daiichi Sankyo, where his work led to multiple drug approvals.
Full founder directory · Investor directory · Company funding database · Fundraising library